Evolutionary dynamics of cancer in response to targeted combination therapy

I. Božić, J. Reiter, B. Allen, T. Antal, K. Chatterjee, P. Shah, Y. Moon, A. Yaqubie, N. Kelly, D. Le, E. Lipson, P. Chapman, L. Diaz, B. Vogelstein, M. Nowak, ELife 2 (2013).

Download
OA IST-2013-134-v1+1_e00747.full.pdf 3.36 MB

Journal Article | Published | English
Author
Božić, Ivana; Reiter, JohannesIST Austria ; Allen, Benjamin; Antal, Tibor; Chatterjee, KrishnenduIST Austria ; Shah, Preya; Moon, Yo; Yaqubie, Amin; Kelly, Nicole; Le, Dung; Lipson, Evan; Chapman, Paul
All
Department
Abstract
In solid tumors, targeted treatments can lead to dramatic regressions, but responses are often short-lived because resistant cancer cells arise. The major strategy proposed for overcoming resistance is combination therapy. We present a mathematical model describing the evolutionary dynamics of lesions in response to treatment. We first studied 20 melanoma patients receiving vemurafenib. We then applied our model to an independent set of pancreatic, colorectal, and melanoma cancer patients with metastatic disease. We find that dual therapy results in long-term disease control for most patients, if there are no single mutations that cause cross-resistance to both drugs; in patients with large disease burden, triple therapy is needed. We also find that simultaneous therapy with two drugs is much more effective than sequential therapy. Our results provide realistic expectations for the efficacy of new drug combinations and inform the design of trials for new cancer therapeutics.
Publishing Year
Date Published
2013-06-25
Journal Title
eLife
Volume
2
Article Number
e00747
IST-REx-ID

Cite this

Božić I, Reiter J, Allen B, et al. Evolutionary dynamics of cancer in response to targeted combination therapy. eLife. 2013;2. doi:10.7554/eLife.00747
Božić, I., Reiter, J., Allen, B., Antal, T., Chatterjee, K., Shah, P., … Nowak, M. (2013). Evolutionary dynamics of cancer in response to targeted combination therapy. ELife, 2. https://doi.org/10.7554/eLife.00747
Božić, Ivana, Johannes Reiter, Benjamin Allen, Tibor Antal, Krishnendu Chatterjee, Preya Shah, Yo Moon, et al. “Evolutionary Dynamics of Cancer in Response to Targeted Combination Therapy.” ELife 2 (2013). https://doi.org/10.7554/eLife.00747.
I. Božić et al., “Evolutionary dynamics of cancer in response to targeted combination therapy,” eLife, vol. 2, 2013.
Božić I, Reiter J, Allen B, Antal T, Chatterjee K, Shah P, Moon Y, Yaqubie A, Kelly N, Le D, Lipson E, Chapman P, Diaz L, Vogelstein B, Nowak M. 2013. Evolutionary dynamics of cancer in response to targeted combination therapy. eLife. 2.
Božić, Ivana, et al. “Evolutionary Dynamics of Cancer in Response to Targeted Combination Therapy.” ELife, vol. 2, e00747, eLife Sciences Publications, 2013, doi:10.7554/eLife.00747.
All files available under the following license(s):
Creative Commons Attribution 4.0 International Public License (CC-BY 4.0):
Main File(s)
Access Level
OA Open Access
Date Uploaded
2018-12-12
MD5 Checksum
2c38c47815eacd8fa66cb8b404cf7c61


Material in IST:
Dissertation containing IST record

Export

Marked Publications

Open Data IST Research Explorer

Search this title in

Google Scholar